Özet:

Purpose: Assess the safety, effectiveness and long-term results of percutaneous aspiration and ethanol sclerotherapy (PAS) in the treatment of symptomatic kidney cysts Method and method: 82 patients treated with percutaneous aspiration and ethanol sclerotherapy in the treatment between 2004 and 2020, 90 cysts were considered retrospective. The average patient age was 60.6 (28-86) and 67 patients were treated for fat pain (81.8%) and 7 patients were treated for hypertension (8.6%) and 3 patients were treated for hydronephrozis (3.5%) The average tracking time was 59 months (1-220 months). After the initiative consistently 1, 3, 6, 12, 18. It was followed for 24 months and years later. Results: Technical success was 100%. There was no mortality associated with the procedure. After the procedure 3 (3.9%) patients had side pain, 1 (1.3%) patients had hematures developed. Five of the patients left their tracking in the first year. At the end of the first year, the average cyst volume decreased by 93% and 19 of the cysts completely disappeared. At the end of a year of tracking, a full/total radiological response was found in 67 of 77 patients (78); a partial response was found in 13 patients. Five patients had no radiological response to the treatment. The PAS, accompanied by ultrasound in the treatment of symptomatic kidney cysts, is a simple, well tolerated technique and can be safely applied with low risk of complications and high technical success.

Anahtar Kelimeler: